Vestibular Migraine
32
3
5
12
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 32 trials
100.0%
+13.5% vs benchmark
3%
1 trials in Phase 3/4
25%
3 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 12 completed trials
Clinical Trials (32)
Validation of the Vestibular Migraine Patient Assessment Tool and Handicap Inventory (VM-PATHI) for Adolescents
Genetic and Biohumoral Factors Involved in Menière's Disease and Their Correlation With Phenotypes
Comparison of Amitriptyline to Lifestyle Modification as Intervention for Vestibular Migraine
Virtual Reality-Based Vestibular Rehabilitation in Vestibular Migraine
Health Belief Model Scale Development for Disability and Abilities in Vestibular Migraine Patients
Virtual Reality and Biofeedback for Adolescents With Chronic Dizziness
Exploring Mild Electrical Vestibular Stimulation as a New Treatment for Dizziness and Migraine Symptoms
Chinese Real-world Study of Treatment of Vestibular Migraine
The Effect of Bone-Conducted Stimulation on Rotary Chair Time Constants in Patients With Vestibular Migraines
China Headache and Vertigo Registry Study
The R-E-V-I-V-A-L Study
Local Sensory Nerve Block in the Treatment of Vestibular Migraine
International Headache Registry Study
A Clinical Trial of Rimegepant for Vestibular Migraine Evaluation: Pre-experiment
Analysis of Vestibular Compensation Following Clinical Intervention for Vestibular Schwannoma
Treating the Symptoms of Vertigo in a Real-world Setting Using the OtoBand
SENSE-VM: Safety and Effectiveness of a Novel Medical Device for Symptom Ease in Vestibular Migraines
Galcanezumab for Vestibular Migraine
4-Aminopyridine, Atenolol, or Placebo in Patients With Vestibular Migraine
CAVA: Dizziness Trial